United States · FDA National Drug Code directory
Lisinopril
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 43547-417_1ed80b02-cb3b-41c5-ab33-ff0106b8792d
- Product NDC
- 43547-417
- Form
- TABLET
- Composition / generic term
- Lisinopril
- Labeler
- Solco healthcare U.S., LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20170830
- Source listing expiry
- 20261231
Source-listed ingredients
- LISINOPRIL — 20 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 45 TABLET in 1 BOTTLE (43547-417-04) · 43547-417-04
- 90 TABLET in 1 BOTTLE (43547-417-09) · 43547-417-09
- 100 TABLET in 1 BOTTLE (43547-417-10) · 43547-417-10
- 1000 TABLET in 1 BOTTLE (43547-417-11) · 43547-417-11
- 5000 TABLET in 1 BOTTLE (43547-417-15) · 43547-417-15
- 500 TABLET in 1 BOTTLE (43547-417-50) · 43547-417-50
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →